Blue Cross and Blue Shield of Massachusetts reported a net loss of $222.8 million and a -2.2% profit margin in 2025, citing unprecedented medical and pharmacy spending.
The company’s annual revenue was $10.3 billion. It posted an operating loss of $380.5 million (-3.7% operating margin), and an investment income of $157.7 million. In the fourth quarter, the company reported a net loss of $121.5 million on revenue of $2.6 billion (-4.7% net margin).
In 2024, BCBSMA reported a net loss of $223.6 million (-2.3% net margin) and an operating loss of $400.4 million (-4.3% operating margin).
The company said it is “aggressively managing” administrative spending through layoffs, voluntary separations, real estate consolidation and vendor contract renegotiation. It also dropped GLP-1 coverage for weight loss last year.
